Powered by: Motilal Oswal
Menu
Close X
Nippon India Pharma Fund(G)

Scheme Returns

-4.51%

Category Returns

-4.63%

Riskometer

  • Low
  • Low to moderate
  • Moderate
  • Moderately High
  • High
  • Very High

NAV Chart

Trailing Returns

1 Day 1 week 1 Mth 3 Mth 1 Yrs 3 Yrs 4 Yrs 5 Yrs Since Inception
Nippon India Pharma Fund(G) 0.03 -0.47 -4.51 -5.27 2.33 20.55 14.59 14.16 19.64
Equity - Sectoral Fund - Pharma & Health Care 0.14 -1.06 -4.63 -6.22 7.40 19.99 16.56 19.33 16.42

* Equity - Returns upto 1 year are absolute and over 1 year are CAGR.

* Debt - Returns upto 1 year are annualized and over 1 year are CAGR.

  • AMC

    Nippon Life India Asset Management Limited

  • Fund

    Nippon India Mutual Fund

Snapshot

  • Inception Date

    05-Jun-2004

  • Initial Price

    ₹10

  • Entry Load

    --

  • Size of Fund(in Cr.)

    451,077.39

  • Scheme Plan

    --

  • Scheme Class

    Equity - Sectoral Fund - Pharma & Health Care

  • Objectives

    The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

  • Scheme Type

    Open ended scheme

  • Min. Investment

    ₹5,000

  • Exit Load

    1

  • Latest NAV

    486.1988

  • Fund Manager

    Mr. Sailesh Raj Bhan

  • Fund Manager Profile

    Sailesh has Over 10 years experience in Equity Securities research and analysis. he is in Reliance Capital Asset Management Limited as managing various Schemes of Reliance Mutual Fund From 2003 to till date

  • Fund Information

  • AMC

    Nippon Life India Asset Management Limited

  • Address

    4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W) Mumbai - 400 013

  • Phone

    022-68087000

  • Fax

    022-68087097

  • Email

    customercare@nipponindiaim.in

  • Website

    https://mf.nipponindiaim.com/

  • Registrar Agent

  • Registrar

    KFin Technologies Limited

  • Address

    301, Centrium, 3rd Floor, 57, L.B.S. Road Nav Pada, Kurla (West) Mumbai - 400070

  • Phone

    022 - 4617 0911

  • Fax

  • Email

    investorsupport.mfs@kfintech.com

  • Website

    https://mfs.kfintech.com/

Portfolio Details

Allocation
Equity : 97.37
Others : 2.63

Companies - Holding Percentage

Company Market Value hold percentage
Sun Pharmaceutical Industries Limited 107590.43 13.02
Lupin Limited 60837.79 7.36
Divi's Laboratories Limited 54384.45 6.58
Cipla Limited 52820.75 6.39
Dr. Reddy's Laboratories Limited 49788.96 6.02
Apollo Hospitals Enterprise Limited 45691.39 5.53
Vijaya Diagnostic Centre Limited 30627.72 3.71
MedPlus Health Services Limited 29283.01 3.54
Ajanta Pharma Limited 26562.69 3.21
Sai Life Sciences Limited 23216.39 2.81
GlaxoSmithKline Pharmaceuticals Limited 22589.56 2.73
Abbott India Limited 21532.78 2.61
Aurobindo Pharma Limited 20142.11 2.44
Thyrocare Technologies Limited 19575.68 2.37
JB Chemicals & Pharmaceuticals Limited 18190.61 2.2
Dr. Lal Path Labs Limited 18061.39 2.19
Alkem Laboratories Limited 17823.33 2.16
Narayana Hrudayalaya Limited 17480.4 2.12
IPCA Laboratories Limited 16943.99 2.05
Mankind Pharma Limited 16638.4 2.01
Pfizer Limited 15873.31 1.92
Gland Pharma Limited 13785.45 1.67
Triparty Repo 13568.29 1.64
Suraksha Diagnostic Limited 10506.51 1.27
Emcure Pharmaceuticals Limited 10183.77 1.23
Fortis Healthcare Limited 9758.38 1.18
Sanofi Consumer Healthcare India Limited 9657.17 1.17
Sanofi India Limited 9411.68 1.14
Max Healthcare Institute Limited 9315.39 1.13
Syngene International Limited 8987 1.09
Biocon Limited 8742.11 1.06
Net Current Assets 8123.79 0.98
Anthem Biosciences Limited 6896.15 0.83
Akums Drugs and Pharmaceuticals Limited 6870.21 0.83
AstraZeneca Pharma India Limited 5649.26 0.68
Indoco Remedies Limited 4304.73 0.52
Orchid Pharma Limited 3472.66 0.42
Concord Biotech Limited 1503.55 0.18
Cash Margin - CCIL 79.75 0.01

Sectors - Holding Percentage

Sector hold percentage
Healthcare 92.74%
Retailing 3.54%
Miscellaneous 1.64%
Business Services 1.09%
Others 0.99%

Divident Details

Scheme Name Date Dividend (%)
No Data Found

Alternative Funds From Category

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
HDFC Pharma and Healthcare Fund - Growth Option 506.59 -4.6 -4.89 -6.9 6.46 0
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 102.69 -5.39 -7.56 -7.77 3.8 0
Nippon India Pharma Fund-Growth Plan-Growth 4510.77 -4.51 -5.27 -8.21 2.33 20.55
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 2552.23 -6.3 -7.65 -8.71 2.05 25.65
UTI Healthcare Fund - Regular Plan - Growth Option 5.42 -5.32 -7.73 -9.28 1.82 22.65
Mirae Asset Healthcare Fund -Regular Growth 1583.14 -5.29 -6.82 -8.68 1.09 20.05
Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth 453.42 -4 -5.32 -6.91 0.82 20.65
Baroda BNP Paribas Health and Wellness Fund Regular Growth 630.97 -4.2 -7.14 -10.42 0 0
Bandhan Healthcare Fund - Regular Plan - Growth 291.59 -6.51 0 0 0 0
SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH 7.7 -4.22 -7.56 -8.43 -0.08 22.36

Other Funds From - Nippon India Pharma Fund(G)

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
Nippon India Small Cap Fund - Growth Plan - Growth Option 68969.15 -6.33 -9.21 -8.82 0.73 20.16
Nippon India Small Cap Fund - Growth Plan - Growth Option 68571.85 -6.33 -9.21 -8.82 0.73 20.16
Nippon India Small Cap Fund - Growth Plan - Growth Option 68287.15 -6.33 -9.21 -8.82 0.73 20.16
Nippon India Small Cap Fund - Growth Plan - Growth Option 66601.8 -6.33 -9.21 -8.82 0.73 20.16
Nippon India Small Cap Fund - Growth Plan - Growth Option 66136.11 -6.33 -9.21 -8.82 0.73 20.16
Nippon India Small Cap Fund - Growth Plan - Growth Option 65922 -6.33 -9.21 -8.82 0.73 20.16
Nippon India Small Cap Fund - Growth Plan - Growth Option 64821.04 -6.33 -9.21 -8.82 0.73 20.16
Nippon India Small Cap Fund - Growth Plan - Growth Option 63006.73 -6.33 -9.21 -8.82 0.73 20.16
Nippon India Small Cap Fund - Growth Plan - Growth Option 62259.56 -6.33 -9.21 -8.82 0.73 20.16
Nippon India Small Cap Fund - Growth Plan - Growth Option 61973.76 -6.33 -9.21 -8.82 0.73 20.16